
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E482AF8AEEDF530582AF003210065C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ccdr">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Canada Communicable Disease Report">
<meta name="citation_title" content="National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern">
<meta name="citation_author" content="Simone Périnet">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Anson Williams">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Laurence Campeau">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Janelle Elliott">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Fan Zhang">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Qiuying Yang">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author_institution" content="Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC">
<meta name="citation_author" content="Joseph Cox">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author_institution" content="Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC">
<meta name="citation_author" content="Karelyn Davis">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_author" content="Jordan J Feld">
<meta name="citation_author_institution" content="Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON">
<meta name="citation_author" content="Marina B Klein">
<meta name="citation_author_institution" content="Research Institute of the McGill University Health Centre, Montréal, QC">
<meta name="citation_author_institution" content="CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research (CTN+), Montréal, QC">
<meta name="citation_author" content="Nadine Kronfli">
<meta name="citation_author_institution" content="Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montréal, QC">
<meta name="citation_author_institution" content="Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC">
<meta name="citation_author" content="Mia J Biondi">
<meta name="citation_author_institution" content="School of Nursing, York University, Toronto, ON">
<meta name="citation_author" content="Peter K Daley">
<meta name="citation_author_institution" content="Memorial University of Newfoundland, St. John’s, NL">
<meta name="citation_author" content="Nashira Popovic">
<meta name="citation_author_institution" content="Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON">
<meta name="citation_publication_date" content="2025 Jul 1">
<meta name="citation_volume" content="51">
<meta name="citation_issue" content="6-7">
<meta name="citation_firstpage" content="223">
<meta name="citation_doi" content="10.14745/ccdr.v51i67a02">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/pdf/CCDR-51-223.pdf">
<meta name="description" content="Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of morbidity and mortality worldwide. Measuring the epidemiological burden of HCV and HBV in Canada is essential to measure progress towards global elimination targets ...">
<meta name="og:title" content="National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of morbidity and mortality worldwide. Measuring the epidemiological burden of HCV and HBV in Canada is essential to measure progress towards global elimination targets ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372649">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.14745/ccdr.v51i67a02"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/CCDR-51-223.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372649%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372649/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372649/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ccdr.png" alt="Canada Communicable Disease Report logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Canada Communicable Disease Report" title="Link to Canada Communicable Disease Report" shape="default" href="http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/index-eng.php" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Can Commun Dis Rep</button></div>. 2025 Jul 1;51(6-7):223–237. doi: <a href="https://doi.org/10.14745/ccdr.v51i67a02" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.14745/ccdr.v51i67a02</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Can%20Commun%20Dis%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Can%20Commun%20Dis%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Can%20Commun%20Dis%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Can%20Commun%20Dis%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rinet%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Simone Périnet</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Simone Périnet</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rinet%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simone Périnet</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Williams%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Anson Williams</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Anson Williams</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Williams%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anson Williams</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Campeau%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Laurence Campeau</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Laurence Campeau</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Campeau%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laurence Campeau</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elliott%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Janelle Elliott</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Janelle Elliott</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Elliott%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Janelle Elliott</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Fan Zhang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Fan Zhang</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fan Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Qiuying Yang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Qiuying Yang</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">
<sup>2</sup>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiuying Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cox%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Joseph Cox</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Joseph Cox</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">
<sup>2</sup>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cox%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph Cox</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Davis%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Karelyn Davis</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Karelyn Davis</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Davis%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Karelyn Davis</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feld%20JJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jordan J Feld</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jordan J Feld</span></h3>
<div class="p">
<sup>3</sup>Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feld%20JJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Jordan J Feld</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Klein%20MB%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Marina B Klein</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Marina B Klein</span></h3>
<div class="p">
<sup>4</sup>Research Institute of the McGill University Health Centre, Montréal, QC</div>
<div class="p">
<sup>5</sup>CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research (CTN+), Montréal, QC</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Klein%20MB%22%5BAuthor%5D" class="usa-link"><span class="name western">Marina B Klein</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kronfli%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Nadine Kronfli</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Nadine Kronfli</span></h3>
<div class="p">
<sup>6</sup>Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montréal, QC</div>
<div class="p">
<sup>7</sup>Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kronfli%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nadine Kronfli</span></a>
</div>
</div>
<sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biondi%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Mia J Biondi</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Mia J Biondi</span></h3>
<div class="p">
<sup>8</sup>School of Nursing, York University, Toronto, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biondi%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Mia J Biondi</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daley%20PK%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Peter K Daley</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Peter K Daley</span></h3>
<div class="p">
<sup>9</sup>Memorial University of Newfoundland, St. John’s, NL</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daley%20PK%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter K Daley</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Popovic%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Nashira Popovic</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Nashira Popovic</span></h3>
<div class="p">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Popovic%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nashira Popovic</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON</div>
<div id="aff2">
<sup>2</sup>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC</div>
<div id="aff3">
<sup>3</sup>Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON</div>
<div id="aff4">
<sup>4</sup>Research Institute of the McGill University Health Centre, Montréal, QC</div>
<div id="aff5">
<sup>5</sup>CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research (CTN+), Montréal, QC</div>
<div id="aff6">
<sup>6</sup>Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montréal, QC</div>
<div id="aff7">
<sup>7</sup>Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC</div>
<div id="aff8">
<sup>8</sup>School of Nursing, York University, Toronto, ON</div>
<div id="aff9">
<sup>9</sup>Memorial University of Newfoundland, St. John’s, NL</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">Correspondence: <span>stbbi.estimates.field.surv-itss.estimations.surv.terrain@phac-aspc.gc.ca</span></p>
</div>
<div class="fn" id="fn1">
<p>Authors’ statement</p>
<p>SP — Conceptualization, methodology, formal analysis, validation, writing–original draft, writing–review &amp; editing</p>
<p>AW — Methodology, formal analysis, validation</p>
<p>LC — Conceptualization, methodology, formal analysis, validation</p>
<p>JE — Methodology, formal analysis</p>
<p>FZ — Methodology, formal analysis</p>
<p>QY — Conceptualization, methodology, formal analysis</p>
<p>JC — Methodology, validation</p>
<p>KD — Methodology, validation</p>
<p>JJF — Methodology, validation</p>
<p>MBK — Methodology, validation</p>
<p>NK — Methodology, validation</p>
<p>MJB — Methodology, validation</p>
<p>PKD — Methodology, validation</p>
<p>NP — Conceptualization, methodology, validation, supervision</p>
<p>All authors approved the final version of the manuscript.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p">
<section id="article-meta1" class="series-info"><h3 class="pmc_sec_title">Series information</h3>
<p>Hepatitis B &amp; C Viruses in Canada</p></section><section id="historyarticle-meta1" class="history"><p>Collection date 2025 Jul.</p></section>
</div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372649</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of morbidity and mortality worldwide. Measuring the epidemiological burden of HCV and HBV in Canada is essential to measure progress towards global elimination targets and to ultimately eliminate viral hepatitis as a public health concern.</p></section><section id="sec2"><h3 class="pmc_sec_title">Objective</h3>
<p>This study aimed to provide the first national estimates of HBV prevalence and unawareness, and to update estimates of HCV incidence, prevalence, and unawareness in the general population and key populations in Canada for 2021. Progress towards elimination targets for 2025, namely incidence, awareness, mortality, and HBV vaccination, was also assessed.</p></section><section id="sec3"><h3 class="pmc_sec_title">Methods</h3>
<p>A combination workbook method and mathematical modelling was used to estimate the prevalence and unawareness of chronic hepatitis B (CHB), prevalence and incidence of anti-HCV antibodies, and the prevalence and unawareness of chronic hepatitis C (CHC).</p></section><section id="sec4"><h3 class="pmc_sec_title">Results</h3>
<p>The estimated prevalence of CHB was 0.68% (plausible range: 0.40%–0.97%) or 262,000 (152,000–371,000) people in the general population, of whom 42.5% (33.9%–51.0%) were unaware of their infection. Immigrants from countries where HBV is common had the highest prevalence at 4.2% (1.9%–5.6%). An estimated 8,212 new HCV infections occurred in 2021, and the estimated prevalence of CHC was 0.56% (0.15%–0.97%) or 214,000 (58,500–369,000) people, of whom 41.5% (34.3%–48.8%) were unaware of their infection. People who inject drugs had the highest prevalence and largest proportion who were unaware at 36.9% (12.6%–55.1%) and 49.9% (29.0%–70.2%), respectively.</p></section><section id="sec5"><h3 class="pmc_sec_title">Conclusion</h3>
<p>While the overall viral hepatitis burden is low in the general Canadian population, these estimates indicate that certain populations and communities remain disproportionately affected. Although Canada has met some of the 2025 targets, more work is needed. To this end, efforts to obtain and standardize provincial and national data will be required to measure progress towards all elimination targets.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords: </strong> viral hepatitis, hepatitis B, hepatitis C, prevalence, incidence, key populations, estimations, Canada</p></section></section><section id="sec6"><h2 class="pmc_sec_title">Introduction</h2>
<p>Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are sexually transmitted and blood-borne infections (STBBI) leading to chronic liver disease with a risk of progression to cirrhosis, liver failure and liver cancer (<a href="#r1" class="usa-link" aria-describedby="r1">1</a>), despite the availability of effective treatment and HBV vaccines. Following HBV infection, approximately 90% of newborns, 20%–30% of children younger than five years, and 5%–10% of adults younger than 50 years develop chronic hepatitis B (CHB) ((<a href="#r2" class="usa-link" aria-describedby="r2">2</a>,<a href="#r3" class="usa-link" aria-describedby="r3">3</a>)) which may cause progressive liver injury. Suppressive treatment is available ((<a href="#r3" class="usa-link" aria-describedby="r3">3</a>)) and reduces the risk of liver-related outcomes but must be taken long-term and rarely leads to clearance of the infection. People exposed to and infected with HCV develop antibodies that remain detectable regardless of spontaneous clearance or successful treatment. Detection of viral RNA is necessary to diagnose chronic hepatitis C (CHC) infection, defined as persistence of viremia beyond six months ((<a href="#r4" class="usa-link" aria-describedby="r4">4</a>)). More than 95% of people who take direct-acting antivirals (DAAs) treatment achieve a sustained virological response 12 weeks after the end of treatment and are therefore considered cured ((<a href="#r5" class="usa-link" aria-describedby="r5">5</a>)). Treatment is well tolerated and recommended for all people living with CHC ((<a href="#r6" class="usa-link" aria-describedby="r6">6</a>)).</p>
<p>Key guiding documents identify certain populations and communities that are disproportionately impacted by HBV and HCV (<a href="#r7" class="usa-link" aria-describedby="r7">7</a>–<a href="#r10" class="usa-link" aria-describedby="r10">10</a>), including immigrants from countries where HBV or HCV is common, gay, bisexual and other men who have sex with men (GBMSM), incarcerated people, people who inject drugs (PWID), First Nations, Inuit and Métis, and adults in the 1945–1975 birth cohort. Canada is committed to achieving the global targets in support of eliminating viral hepatitis as a public health concern ((<a href="#r8" class="usa-link" aria-describedby="r8">8</a>,<a href="#r11" class="usa-link" aria-describedby="r11">11</a>)). Global targets include a reduction of incidence and mortality, an increase in the proportion of people living with CHC or CHB who are diagnosed and treated, and an increase of HBV vaccine coverage.</p>
<p>This paper provides updated national estimates of HCV incidence, prevalence, awareness and treatment, as well as the first national estimates of HBV prevalence and awareness, for 2021 ((<a href="#r9" class="usa-link" aria-describedby="r9">9</a>)). These estimates are reported for the general population, as well as for key populations. Finally, Canada’s progress towards some of the 2025 global viral hepatitis elimination targets are discussed.</p></section><section id="sec7"><h2 class="pmc_sec_title">Methods</h2>
<p>A combination of a modified workbook method and mathematical modelling was used to estimate the prevalence of CHB and the proportion of people living with CHB who were unaware of their infection, and to estimate the prevalence of anti-HCV antibodies and CHC and the proportion of people living with CHC who were unaware of their infection. Incidence for HCV was estimated using mathematical modelling. Mortality, HBV vaccination and HCV treatment were estimated using administrative data. Rates were calculated using national population estimates ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>)).</p>
<section id="sec8"><h3 class="pmc_sec_title">Hepatitis B</h3>
<section id="sec9"><h4 class="pmc_sec_title">Systematic review</h4>
<p>A systematic search for literature published between January 1, 2016 and March 31, 2023, on prevalence and unawareness of HBV infection in Canada was conducted in the MEDLINE, Embase and Scopus databases and yielded an initial 355 records, with an additional 40 records identified through other sources. Using a previously described method ((<a href="#r13" class="usa-link" aria-describedby="r13">13</a>)), 14 records were selected to consider in the workbook method, in addition to unpublished data from organizations and researchers.</p></section><section id="sec10"><h4 class="pmc_sec_title">Mathematical modelling</h4>
<p>National CHB modelling was described elsewhere ((<a href="#r14" class="usa-link" aria-describedby="r14">14</a>)) and used data from the Canadian Notifiable Disease Surveillance System (CNDSS), extracted in July 2023 for all provinces and territories, as input into the model.</p></section><section id="sec11"><h4 class="pmc_sec_title">Modified workbook</h4>
<p>A modified workbook method ((<a href="#r13" class="usa-link" aria-describedby="r13">13</a>)) was used to estimate the prevalence of CHB infection (using the hepatitis B surface antigen (HBsAg) as a proxy for CHB, where applicable), and its proportion unaware, for the general population and for key populations informed by an environmental scan. Each measure extracted from the systematic search records were classified as “underestimate,” “appropriate estimate” or “overestimate” based on a review of the methodology of each study. The underestimates and overestimates were used as plausible ranges. When measures from multiple records were available, evidence was ranked to prioritize representative data (e.g., national surveys) over data of lower representativity (e.g., local studies) to determine each plausible range. Where possible, results from comparable studies were averaged. Point estimates were calculated as the midpoint between bounds, except when representative data (“appropriate estimates”) were used as the point estimate. In instances where only one representative estimate was available, the plausible range is the 95% confidence interval, computed as needed using the Wilson method ((<a href="#r15" class="usa-link" aria-describedby="r15">15</a>)). In instances where there was one data source of low representativity or no data, “insufficient data” was indicated. Proportions ≤1 were rounded to two decimal places, larger proportions were rounded to one decimal place, and absolute numbers were rounded to three significant digits.</p></section><section id="sec12"><h4 class="pmc_sec_title">Administrative data: Vaccination and mortality</h4>
<p>Vital statistics data ((<a href="#r16" class="usa-link" aria-describedby="r16">16</a>)) were used to estimate the proportion of all live births in Canada that occurred in provinces and territories offering universal birth dose vaccination. Vaccination coverage was taken from the <em>Childhood National Immunization Coverage Survey</em> report ((<a href="#r17" class="usa-link" aria-describedby="r17">17</a>)).</p>
<p>Vital statistics data were used to directly estimate the number of deaths in 2021 for which HBV (ICD-10 codes B16.0, B16.1, B16.2, B16.9, B17.0, B18.0, and B18.1) was identified as the underlying cause or one of the other 19 contributing causes of death ((<a href="#r18" class="usa-link" aria-describedby="r18">18</a>)).</p></section></section><section id="sec13"><h3 class="pmc_sec_title">Hepatitis C</h3>
<section id="sec14"><h4 class="pmc_sec_title">Systematic review</h4>
<p>A search on prevalence, incidence and unawareness of infection in Canada was updated with records published between July 1, 2021 and March 31, 2023, yielding 187 records, with an additional 28 records found outside of the search. A total of 31 records were selected for consideration using the workbook method, in addition to the 22 records identified and used through the 2019 estimates process ((<a href="#r13" class="usa-link" aria-describedby="r13">13</a>)) and unpublished data from organizations and researchers.</p></section><section id="sec15"><h4 class="pmc_sec_title">Mathematical modelling</h4>
<p>Back-calculation mathematical modelling ((<a href="#r7" class="usa-link" aria-describedby="r7">7</a>,<a href="#r19" class="usa-link" aria-describedby="r19">19</a>)) with least square method ((<a href="#r20" class="usa-link" aria-describedby="r20">20</a>)) for 2020–2021 pandemic adjustment was used to estimate HCV incidence and as input for the anti-HCV antibodies prevalence estimates. Data from a July 2023 CNDSS extraction for British Columbia, Alberta, Saskatchewan, Ontario, Québec and the Yukon were used as input and model outputs were projected to Canadian population.</p></section><section id="sec16"><h4 class="pmc_sec_title">Modified workbook</h4>
<p>Using methods described in the HBV section, this study estimated the prevalence of anti-HCV antibodies (as a marker of current or past infection) as well as the prevalence of CHC infection (using detection of HCV RNA as a proxy where applicable) and its proportion unaware, for the general population and for key populations, based on priority populations identified in the blueprint to inform hepatitis C elimination efforts in Canada ((<a href="#r7" class="usa-link" aria-describedby="r7">7</a>)).</p></section><section id="sec17"><h4 class="pmc_sec_title">Administrative data: Treatment and mortality</h4>
<p>Licensed data were obtained from IQVIA Solutions Canada (IQVIA) to estimate the number of people treated for HCV in Canada between 2012 and 2021. The 2012–2016 estimates were produced by the British Columbia Centre for Disease Control using Compuscript data from IQVIA, and the 2017–2021 estimates were projected patient counts computed by IQVIA using the GPM Custom Solutions information service.</p>
<p>Vital statistics data were used to directly estimate the number of deaths in 2021 for which HCV (ICD-10 codes B17.1 and B18.2) was identified as an underlying cause or one of the other 19 contributing causes of death ((<a href="#r18" class="usa-link" aria-describedby="r18">18</a>)).</p></section></section></section><section id="sec18"><h2 class="pmc_sec_title">Results</h2>
<section id="sec19"><h3 class="pmc_sec_title">Chronic hepatitis B prevalence</h3>
<p>The prevalence of CHB in the general population was estimated at 0.68% (plausible range: 0.40%–0.97%) or 262,000 (152,000–371,000) people at the end of 2021. Among key populations, the highest estimated prevalence was 4.2% (1.9%–5.6%) among immigrants from countries where HBV is common (≥2% HBsAg prevalence), followed by GBMSM at 1.4% (0.8%–2.1%) and people incarcerated in federal prisons (<a href="#t1" class="usa-link"><strong>Table 1</strong></a>). Additional data are needed to estimate the prevalence in other key populations.</p>
<section class="tw xbox font-sm" id="t1"><h4 class="obj_head">Table 1. Estimated chronic hepatitis B prevalence for the general population and key populations, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="15.14%" span="1">
<col width="11.05%" span="1">
<col width="10.28%" span="1">
<col width="9.34%" span="1">
<col width="9.34%" span="1">
<col width="10.28%" span="1">
<col width="10.28%" span="1">
<col width="8.41%" span="1">
<col width="15.88%" span="1">
<thead>
<tr>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population size estimate</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Prevalence (%)</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Estimated number of people living with CHB</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Reference(s)</th>
</tr>
<tr>
<th valign="middle" colspan="1" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">General population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">38,239,864</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.68%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.40%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.97%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">262,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">152,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">371,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r14" class="usa-link" aria-describedby="r14">14</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>–<a href="#r24" class="usa-link" aria-describedby="r24">24</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Immigrants from countries where HBV is common (HBsAg ≥2%)</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5,599,485</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">4.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.6%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">237,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">106,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">312,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r25" class="usa-link" aria-describedby="r25">25</a>,<a href="#r26" class="usa-link" aria-describedby="r26">26</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">GBMSM</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">669,613</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.4%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.8%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,310</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5,360</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">14,100</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r27" class="usa-link" aria-describedby="r27">27</a>,<a href="#r28" class="usa-link" aria-describedby="r28">28</a>))<br>Unpublished data from the Engage cohort study, 2017–2019</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in federal prisons<sup>a</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12,405</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.28%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.19%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.41%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">35</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">24</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">51</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">Unpublished data from Correctional Service Canada, 2021 (<em>personal communication, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in provincial prisons<sup>b</sup>
</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">PWID</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">First Nations</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Inuit</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Métis</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p37">
<p>Abbreviations: CHB, chronic hepatitis B; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; GBMSM, gay, bisexual and other men who have sex with men; PWID, people who inject drugs</p>
<p><sup>a</sup> Who were sentenced for two years or more</p>
<p><sup>b</sup> Who were sentenced for less than two years</p>
</div></div></section></section><section id="sec20"><h3 class="pmc_sec_title">Unawareness of chronic hepatitis B infection</h3>
<p>The proportion of people living with CHB who were unaware of their infection was estimated at 42.5% (33.9%–51.0%), or 111,000 (88,700–134,000) people (<a href="#t2" class="usa-link"><strong>Table 2</strong></a>). Additional data are needed to estimate unawareness in key populations.</p>
<section class="tw xbox font-sm" id="t2"><h4 class="obj_head">Table 2. Estimated number and proportion of people living with chronic hepatitis B who were unaware of their infection for the general population and key populations, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="14.5%" span="1">
<col width="12.25%" span="1">
<col width="10.59%" span="1">
<col width="8.8%" span="1">
<col width="8.73%" span="1">
<col width="10.59%" span="1">
<col width="9.14%" span="1">
<col width="10.39%" span="1">
<col width="15.01%" span="1">
<thead>
<tr>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Estimated number of people living with CHB</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Proportion who were unaware (%)</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Estimated number of people who were unaware</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Reference(s)</th>
</tr>
<tr>
<th valign="middle" colspan="1" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">General population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">262,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">42.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">33.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">51.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">111,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">88,700</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">134,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r14" class="usa-link" aria-describedby="r14">14</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Immigrants from countries where HBV is common (HBsAg ≥2%)</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">GBMSM</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in federal prisons<sup>a</sup>
</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in provincial prisons<sup>b</sup>
</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">PWID</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">First Nations</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Inuit</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Métis</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p41">
<p>Abbreviations: CHB, chronic hepatitis B; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; GBMSM, gay, bisexual and other men who have sex with men; PWID, people who inject drugs</p>
<p><sup>a</sup> Who were sentenced for two years or more</p>
<p><sup>b</sup> Who were sentenced for less than two years</p>
</div></div></section></section><section id="sec21"><h3 class="pmc_sec_title">Hepatitis B vaccination</h3>
<p>In the seven jurisdictions with a three-dose program for infants, the HBV vaccine coverage among two-year-old children was 82.6% (79.7%–85.1%) in 2021. The national HBV vaccine coverage among 14-year-old adolescents was 89.0% (86.3%–91.2%) in 2021 ((<a href="#r17" class="usa-link" aria-describedby="r17">17</a>)).</p>
<p>Three (New Brunswick, Northwest Territories and Nunavut) out of 13 provinces and territories have universal HBV vaccination programs initiated at birth, and 7,690 live births occurred in these jurisdictions between July 1, 2021 and June 30, 2022, representing 2% of live births in Canada during that period ((<a href="#r16" class="usa-link" aria-describedby="r16">16</a>)).</p></section><section id="sec22"><h3 class="pmc_sec_title">Hepatitis B-related mortality</h3>
<p>In 2021, HBV was identified as a contributing cause for 274 deaths for a crude mortality rate of 0.72 per 100,000 population. Between 2015 and 2021, the annual mortality rate for HBV-related deaths was relatively stable (<a href="#f1" class="usa-link"><strong>Figure 1</strong></a>).</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372649_516702-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/809e/12372649/8f37ca34a911/516702-f1.jpg" loading="lazy" height="562" width="785" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Crude annual hepatitis B-related and hepatitis C-related mortality rates (per 100,000 population), Canada, 2015–2021</p></figcaption></figure></section><section id="sec23"><h3 class="pmc_sec_title">Hepatitis C incidence</h3>
<p>An estimated 8,212 seroconversions (representing new HCV infections) occurred in 2021 in Canada, corresponding to an annual incidence rate of 21.47 per 100,000 population. The overall incidence rate has been slowly declining since 2013 (<a href="#f2" class="usa-link"><strong>Figure 2</strong></a>). When grouped by birth cohort, as a proxy for established generations, those born between 1980 and 1994 had the highest incidence in 2021 (Figure 2) with 3,179 estimated seroconversions, for a rate of 39.76 per 100,000 population (data not shown).</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372649_516702-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/809e/12372649/b400a9347143/516702-f2.jpg" loading="lazy" height="316" width="775" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Estimated annual hepatitis C incidence rates (per 100,000 population), by birth cohort and overall, Canada, 2001–2021</p></figcaption></figure></section><section id="sec24"><h3 class="pmc_sec_title">Hepatitis C prevalence</h3>
<p>The estimated prevalence of anti-HCV antibodies in Canada was 0.99% (0.68%–1.30%) or 378,000 (258,000–497,000) people who were ever infected with HCV at the end of 2021. Among key populations, the highest estimated prevalence was among PWID (within 12 months) at 64.2% (36.7%–91.8%), followed by those who have ever injected drugs (35.4%; 9.3%–61.5%). In absolute numbers, adults in the 1945–1975 birth cohort represented the population with the largest number of people ever infected at 270,000 (157,000–383,000) (<a href="#t3" class="usa-link"><strong>Table 3</strong></a>).</p>
<section class="tw xbox font-sm" id="t3"><h4 class="obj_head">Table 3. Estimated anti-hepatitis C virus antibodies prevalence for the general population and key populations, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="11.93%" span="1">
<col width="11.01%" span="1">
<col width="9.75%" span="1">
<col width="9.52%" span="1">
<col width="10.55%" span="1">
<col width="10.11%" span="1">
<col width="8.66%" span="1">
<col width="10.12%" span="1">
<col width="18.35%" span="1">
<thead>
<tr>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population size estimate</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Prevalence (%)</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Estimated number of people with current or past HCV infection</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Reference(s)</th>
</tr>
<tr>
<th valign="middle" colspan="1" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">General population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">38,239,864</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.99%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.68%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.3%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">378,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">258,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">497,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r29" class="usa-link" aria-describedby="r29">29</a>–<a href="#r31" class="usa-link" aria-describedby="r31">31</a>))<br>Unpublished data from PHAC, 2021 (this study)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">PWID, within 12 months</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">100,300</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">64.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">91.8%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">64,400</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36,800</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">92,100</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r32" class="usa-link" aria-describedby="r32">32</a>–<a href="#r35" class="usa-link" aria-describedby="r35">35</a>))<br>Unpublished data from the Virtual Cascade of Care Cohort study, 2018–2019 (<em>personal communication, Stine Høj, 2023</em>)<br>Unpublished data from the HEPCO study, 2022–2023 (<em>personal communication, Sarah Larney, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People who have ever injected drugs</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">388,400</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">35.4%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9.3%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">61.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">137,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36,100</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">239,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r33" class="usa-link" aria-describedby="r33">33</a>,<a href="#r35" class="usa-link" aria-describedby="r35">35</a>–<a href="#r37" class="usa-link" aria-describedby="r37">37</a>))<br>Unpublished data from the Virtual Cascade of Care Cohort study, 2018–2019 (<em>personal communication, Stine Høj, 2023</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in provincial prisons<sup>a</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">18,950</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">14.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">19.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2,700</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,790</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3,600</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r38" class="usa-link" aria-describedby="r38">38</a>–<a href="#r41" class="usa-link" aria-describedby="r41">41</a>))<br>Unpublished data from Alberta Health Services, 2023 (<em>personal communication, Kaylee Goralcyk, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in federal prisons<sup>b</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12,405</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">11.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">10.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,370</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,260</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,490</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">Unpublished data from Correctional Service Canada, 2021 (<em>personal communication, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">First Nations</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,048,400</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">8.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">84,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36,600</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">131,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r42" class="usa-link" aria-describedby="r42">42</a>–<a href="#r44" class="usa-link" aria-describedby="r44">44</a>))<br>Unpublished data from the CHMS, Statistics Canada, 2014–2015</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Immigrants from countries where hepatitis C is common (≥2% seroprevalence)</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,276,405</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">4.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">6.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">51,500</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36,700</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">85,300</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r25" class="usa-link" aria-describedby="r25">25</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">GBMSM</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">669,613</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.82%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">20,100</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5,490</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">34,800</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r27" class="usa-link" aria-describedby="r27">27</a>,<a href="#r45" class="usa-link" aria-describedby="r45">45</a>,<a href="#r46" class="usa-link" aria-describedby="r46">46</a>))<br>Unpublished data from the Engage cohort study, 2017–2019</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Adults in the 1945–1975 birth cohort</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">14,267,340</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">270,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">157,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">383,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r29" class="usa-link" aria-describedby="r29">29</a>–<a href="#r31" class="usa-link" aria-describedby="r31">31</a>,<a href="#r36" class="usa-link" aria-describedby="r36">36</a>,<a href="#r47" class="usa-link" aria-describedby="r47">47</a>))<br>Unpublished data from PHAC, 2021 (this study)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Inuit</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Métis</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p51">
<p>Abbreviations: CHMS, Canadian Health Measures Survey; HCV, hepatitis C virus; HEPCO, Hepatitis Cohort; GBMSM, gay, bisexual and other men who have sex with men; PHAC, Public Health Agency of Canada; PWID, people who inject drugs</p>
<p><sup>a</sup> Who were sentenced for two years or more</p>
<p><sup>b</sup> Who were sentenced for less than two years</p>
</div></div></section><p>The prevalence of CHC in Canada was estimated at 0.56% (0.15%–0.97%) or 214,000 (58,500–369,000) people living with CHC at the end of 2021. Among key populations, PWID (within 12 months) and those who have ever injected drugs had the highest estimated prevalence of CHC at 36.9% (12.6%–55.1%) and 18.1% (5.7%–30.5%), respectively. In absolute numbers, adults in the 1945–1975 birth cohort had the largest number of people living with CHC at 157,000 (30,000–284,000) (<a href="#t4" class="usa-link"><strong>Table 4</strong></a>).</p>
<section class="tw xbox font-sm" id="t4"><h4 class="obj_head">Table 4. Estimated chronic hepatitis C prevalence for the general population and key populations, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="11.02%" span="1">
<col width="9.36%" span="1">
<col width="9.41%" span="1">
<col width="9.41%" span="1">
<col width="10.55%" span="1">
<col width="10.55%" span="1">
<col width="9.41%" span="1">
<col width="9.41%" span="1">
<col width="20.88%" span="1">
<thead>
<tr>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population size estimate</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Prevalence (%)</th>
<th valign="middle" colspan="3" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Estimated number of people living with CHC</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Reference(s)</th>
</tr>
<tr>
<th valign="middle" colspan="1" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Point estimate</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">General population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">38,239,864</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.56%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.15%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.97%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">214,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">58,500</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">369,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r30" class="usa-link" aria-describedby="r30">30</a>,<a href="#r31" class="usa-link" aria-describedby="r31">31</a>,<a href="#r48" class="usa-link" aria-describedby="r48">48</a>–<a href="#r52" class="usa-link" aria-describedby="r52">52</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">PWID, within 12 months</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">100,300</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">36.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12.6%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">55.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">37,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12,600</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">55,300</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r32" class="usa-link" aria-describedby="r32">32</a>–<a href="#r35" class="usa-link" aria-describedby="r35">35</a>,<a href="#r53" class="usa-link" aria-describedby="r53">53</a>,<a href="#r54" class="usa-link" aria-describedby="r54">54</a>))<br>Unpublished data from the HEPCO study, 2022–2023 (<em>personal communication, Sarah Larney, 2024</em>)<br>Unpublished data from the Virtual Cascade of Care Cohort study, 2018–2019 (<em>personal communication, Stine Høj, 2023</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People who have ever injected drugs</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">388,400</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">18.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">30.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">70,100</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">21,900</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">118,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r35" class="usa-link" aria-describedby="r35">35</a>))<br>Unpublished data from the Virtual Cascade of Care Cohort study, 2018–2019 (<em>personal communication, Stine Høj, 2023</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in provincial prisons<sup>a</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">18,950</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">4.4%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">957</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">834</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,080</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r38" class="usa-link" aria-describedby="r38">38</a>,<a href="#r40" class="usa-link" aria-describedby="r40">40</a>,<a href="#r41" class="usa-link" aria-describedby="r41">41</a>))<br>Unpublished data from Alberta Health Services, 2023 (<em>personal communication, Kaylee Goralcyk, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">First Nations</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,048,400</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.3%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">34,300</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">15,800</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">52,800</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r42" class="usa-link" aria-describedby="r42">42</a>–<a href="#r44" class="usa-link" aria-describedby="r44">44</a>,<a href="#r55" class="usa-link" aria-describedby="r55">55</a>,<a href="#r56" class="usa-link" aria-describedby="r56">56</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in federal prisons<sup>b</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">12,405</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">396</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">335</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">464</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">Unpublished data from Correctional Service Canada, 2021 (<em>personal communication, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Immigrants from countries where hepatitis C is common (≥2% seroprevalence)</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,276,405</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.6%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">28,100</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">19,800</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">44,600</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r25" class="usa-link" aria-describedby="r25">25</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Adults in the 1945–1975 birth cohort</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">14,267,340</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.1%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.21%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">157,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">30,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">284,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r48" class="usa-link" aria-describedby="r48">48</a>,<a href="#r49" class="usa-link" aria-describedby="r49">49</a>,<a href="#r57" class="usa-link" aria-describedby="r57">57</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">GBMSM</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">669,613</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.94%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.18%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">6,290</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">1,210</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">11,400</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r27" class="usa-link" aria-describedby="r27">27</a>,<a href="#r45" class="usa-link" aria-describedby="r45">45</a>,<a href="#r46" class="usa-link" aria-describedby="r46">46</a>))<br>Unpublished data from the Engage cohort study 2017–2019</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Inuit</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Métis</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p55">
<p>Abbreviations: CHC, chronic hepatitis C; HEPCO, Hepatitis Cohort; GBMSM, gay, bisexual and other men who have sex with men; PWID, people who inject drugs</p>
<p><sup>a</sup> Who were sentenced for two years or more</p>
<p><sup>b</sup> Who were sentenced for less than two years</p>
</div></div></section></section><section id="sec25"><h3 class="pmc_sec_title">Unawareness of chronic hepatitis C infection</h3>
<p>The proportion of people living with CHC who were unaware of their infection was estimated at 41.5% (34.3%–48.8%) or 104,000 people. Among key populations, the largest proportion was among PWID at 49.9% (29.0%–70.2%), followed by people incarcerated in federal prisons at 32.7% (28.2%–37.5%). In absolute numbers, adults in the 1945–1975 birth cohort had the largest number of people unaware of their infection at 45,200 (24,700–65,800) (<a href="#t5" class="usa-link"><strong>Table 5</strong></a>). Additional data are needed to estimate unawareness in other key populations.</p>
<section class="tw xbox font-sm" id="t5"><h4 class="obj_head">Table 5. Estimated number and proportion of people living with chronic hepatitis C who were unaware of their infection, for the general population and key populations, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="12.54%" span="1">
<col width="14.16%" span="1">
<col width="10.56%" span="1">
<col width="10%" span="1">
<col width="10.16%" span="1">
<col width="10.91%" span="1">
<col width="8.88%" span="1">
<col width="8.88%" span="1">
<col width="13.91%" span="1">
<thead>
<tr>
<th rowspan="2" valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Population</th>
<th rowspan="2" valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Estimated number of people living with CHC</th>
<th colspan="3" valign="top" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Proportion who were unaware (%)</th>
<th colspan="3" valign="top" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Estimated number of people living with CHC who are unaware</th>
<th rowspan="2" valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" colspan="1">Reference(s)</th>
</tr>
<tr>
<th valign="top" colspan="1" align="center" scope="colgroup" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1">Point estimate</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Point estimate</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Lower bound</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Upper bound</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">General population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">214,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">41.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">34.3%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">48.8%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">104,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">73,300</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">104,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r48" class="usa-link" aria-describedby="r48">48</a>,<a href="#r49" class="usa-link" aria-describedby="r49">49</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">PWID, within 12 months</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">37,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">49.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">29.0%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">70.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">18,500</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">10,700</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">26,000</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r32" class="usa-link" aria-describedby="r32">32</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People who have ever injected drugs</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in provincial prisons<sup>a</sup>
</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">First Nations</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">People incarcerated in federal prisons<sup>b</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">396</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">32.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">28.2%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">37.5%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">129</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">112</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">148</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">Unpublished data from Correctional Services Canada, 2021 (<em>personal communication, 2024</em>)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Adults in the 1945–1975 birth cohort</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">157,000</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">28.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">15.7%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">41.9%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">45,200</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">24,700</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">65,800</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r21" class="usa-link" aria-describedby="r21">21</a>,<a href="#r48" class="usa-link" aria-describedby="r48">48</a>,<a href="#r49" class="usa-link" aria-describedby="r49">49</a>,<a href="#r58" class="usa-link" aria-describedby="r58">58</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Immigrants from countries where hepatitis C is common (≥2% seroprevalence)</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Inuit</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Métis</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">GBMSM</td>
<td colspan="8" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Insufficient information</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p59">
<p>Abbreviations; CHC, chronic hepatitis C; GBMSM, gay, bisexual and other men who have sex with men; PWID; people who inject drugs</p>
<p><sup>a</sup> Who were sentenced for two years or more</p>
<p><sup>b</sup> Who were sentenced for less than two years</p>
</div></div></section></section><section id="sec26"><h3 class="pmc_sec_title">Hepatitis C treatment</h3>
<p>It is estimated that, between 2012 and 2021, 108,000 people living with CHC received treatment. Since the introduction of highly effective DAAs in Canada in 2014, approximately 99,400 people were treated. Between 2015 and 2021, but drastically starting in 2017, the estimated number of people treated annually surpassed the estimated number of new infections annually (<a href="#t6" class="usa-link"><strong>Table 6</strong></a>, <a href="#f3" class="usa-link"><strong>Figure 3</strong></a>).</p>
<section class="tw xbox font-sm" id="t6"><h4 class="obj_head">Table 6. Estimated number of new hepatitis C virus infections and estimated number of people who received hepatitis C virus treatment by year, Canada, 2012–2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="11.71%" span="1">
<col width="41.33%" span="1">
<col width="46.96%" span="1">
<thead><tr>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Year</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Estimated number of new HCV infections</th>
<th valign="middle" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Estimated number of people who received HCV treatment</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2012</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">10,075</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">4,370</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2013</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,912</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">4,221</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2014</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,690</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">5,147</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2015</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,557</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">11,138</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2016</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,580</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">10,496</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2017</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,673</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">14,887</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2018</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,506</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">19,155</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2019</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">9,298</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">16,619</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2020</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">8,086</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">11,774</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">2021</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">8,212</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">10,155</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p63"><p>Abbreviation: HCV, hepatitis C virus</p></div></div></section><figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372649_516702-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/809e/12372649/c184e279af98/516702-f3.jpg" loading="lazy" height="312" width="775" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Estimated annual number of people living with chronic hepatitis C who were treated and estimated annual number of new hepatitis C infections, Canada, 2012–2021</p>
<p>Abbreviation: DAAs, direct-acting antivirals</p></figcaption></figure></section><section id="sec27"><h3 class="pmc_sec_title">Hepatitis C-related mortality</h3>
<p>In 2021, HCV was identified as a contributing cause for 972 deaths for a crude mortality rate of 2.54 per 100,000 population. Between 2010 and 2021, the annual mortality rate decreased, starting in 2016 (Figure 1).</p></section><section id="sec28"><h3 class="pmc_sec_title">Progress towards viral hepatitis elimination</h3>
<p><a href="#t7" class="usa-link"><strong>Table 7</strong></a> summarises the intermediary global targets for 2025 in relation to the 2021 estimates. For HBV, these estimates suggest that, as of 2021, Canada was on track to meet or had met three of the seven targets for 2025. For HCV, these estimates suggest that, as of 2021, Canada was on track to meet or had met three of the eight targets for 2025.</p>
<section class="tw xbox font-sm" id="t7"><h4 class="obj_head">Table 7. Progress towards viral hepatitis elimination targets for 2025 outlined in the Global Health Sector Strategy 2022–2030, Canada, 2021.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="38.18%" span="1">
<col width="20.02%" span="1">
<col width="21.84%" span="1">
<col width="19.96%" span="1">
<thead><tr>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Indicator</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">2025 target ((<a href="#r11" class="usa-link" aria-describedby="r11">11</a>))</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">2021 estimates</th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(54,95,145)" rowspan="1" colspan="1">Reference(s)</th>
</tr></thead>
<tbody>
<tr><td colspan="4" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(149,179,215)" scope="col" rowspan="1">
<strong>Hepatitis B</strong>
</td></tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Hepatitis B surface antigen prevalence among children 0–4 years old</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.5%</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of new hepatitis B infections per year</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">11/100,000 population</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of people dying from hepatitis B per year</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">7/100,000 population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">0.72/100,000 population</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study using Vital statistics data ((<a href="#r18" class="usa-link" aria-describedby="r18">18</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Percentage of newborns who have benefitted from a timely birth dose of hepatitis vaccine and from other interventions to prevent the vertical (mother-to-child) transmission of hepatitis B virus</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">70%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">Less than 2%</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study using Vital statistics data ((<a href="#r18" class="usa-link" aria-describedby="r18">18</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Hepatitis B vaccine coverage among children (third dose)<sup>a</sup>
</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">90%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">89.0% among 14-year-olds,<br>1 or more dose</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r17" class="usa-link" aria-describedby="r17">17</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Percentage of people living with hepatitis B diagnosed</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">60%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">57.5%</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Percentage of people living with hepatitis B diagnosed and treated</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">50%</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr><td colspan="4" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt; background-color:rgb(149,179,215)" scope="col" rowspan="1">
<strong>Hepatitis C</strong>
</td></tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of new hepatitis C infections per year</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">13/100,000 population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">21.47/100,000 population</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of new hepatitis C infections among PWID per year</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3/100</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of people dying from hepatitis C per year</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">3/100,000 population</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">2.54/100,000 population</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study using Vital statistics data ((<a href="#r18" class="usa-link" aria-describedby="r18">18</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Number of needles and syringes distributed per PWID</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">200</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Blood safety: proportion of blood units screened for blood-borne diseases</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">100%</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">100% of blood donations are tested for hepatitis B and C</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1"> ((<a href="#r59" class="usa-link" aria-describedby="r59">59</a>))</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Safe injections: proportion of safe healthcare injections</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">100%</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Percentage of people living with hepatitis C diagnosed</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">60%</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">58.5%</td>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">This study</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" scope="row" rowspan="1" colspan="1">Percentage of people living with hepatitis C diagnosed and cured</td>
<td valign="top" align="right" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1" colspan="1">50%</td>
<td colspan="2" valign="top" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt" rowspan="1">Additional data needed</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p68">
<p>Abbreviation: PWID, people who inject drugs</p>
<p><sup>a</sup> The domestic vaccine coverage goal in Canada is to achieve 90% vaccination coverage by 17 years of age for one or more doses of the hepatitis B vaccine, by 2025 ((<a href="#r60" class="usa-link" aria-describedby="r60">60</a>)). As of 2024, no other domestic targets were set</p>
</div></div></section></section></section><section id="sec29"><h2 class="pmc_sec_title">Discussion</h2>
<p>Although the overall viral hepatitis burden is low in the general Canadian population, the 2021 national estimates indicate that certain populations and communities remain disproportionately affected, and that a significant number of people in Canada would benefit from targeted testing and treatment. These estimates mostly use data sources preceding the COVID-19 pandemic. Measuring post-pandemic estimates will be important to account for decreased demand for, and access to prevention, testing, treatment and care services for HBV and HCV. Given changes in methods and available evidence, these estimates replace previously published estimates and should not be compared over time.</p>
<p>It is estimated that 0.68% of people in Canada were living with CHB at the end of 2021. Other estimates for Canada include a 0.4% prevalence (2007–2011) ((<a href="#r61" class="usa-link" aria-describedby="r61">61</a>)) and a 0.6% HBsAg prevalence (2022) ((<a href="#r62" class="usa-link" aria-describedby="r62">62</a>,<a href="#r63" class="usa-link" aria-describedby="r63">63</a>)), which are comparable to the results in this study. Immigrants from countries where HBV is common have the highest burden, by far. Regarding progress towards HBV elimination, we cannot report on the incidence target using available data. Estimates suggest that Canada is close to meeting the 60% diagnosis target for 2025 with 57.5% people living with CHB who were aware of their infection. Awareness data for key populations is scarce, limiting the evidence base for planning targeted interventions. An estimated 0.72 deaths per 100,000 population were identified as HBV-related in 2021, suggesting that the 2025 target of seven per 100,000 population is met, which is supported by a modelling study estimating one per 100,000 population HBV-related deaths in Canada in 2019 ((<a href="#r64" class="usa-link" aria-describedby="r64">64</a>)). The HBV vaccine coverage of 89% in adolescents approximates the 2025 target of 90% among children. We estimate that less than 2% of infants born in Canada in 2021 had access to universal birth dose vaccination, far from the 70% global target set for 2025. Of note, health care is a provincial and territorial responsibility, and the <em>Canadian Immunization Guide</em> indicates that the HBV vaccine should be provided according to provincial and territorial immunization schedules ((<a href="#r65" class="usa-link" aria-describedby="r65">65</a>)). Hepatitis B treatment data were not nationally validated at the time of press.</p>
<p>An estimated 21.47 new HCV infections per 100,000 population occurred in 2021, highlighting that more prevention work, including harm reduction services in all settings ((<a href="#r8" class="usa-link" aria-describedby="r8">8</a>,<a href="#r10" class="usa-link" aria-describedby="r10">10</a>)), is needed to reduce the incidence of HCV and meet the 2025 target of 13 per 100,000 population. We estimate that 0.99% of the Canadian population was ever infected with HCV. Other estimates include a 0.07% anti-HCV prevalence among Canadian first-time blood donors in nine provinces, representing a low-risk and undiagnosed population ((<a href="#r66" class="usa-link" aria-describedby="r66">66</a>)). We estimate the CHC prevalence at 0.56% in the general population; other CHC estimates include a prevalence of viremic infection of 130,000 people (2022) ((<a href="#r67" class="usa-link" aria-describedby="r67">67</a>)), and of 0.03% among low-risk undiagnosed blood donors (2021) ((<a href="#r66" class="usa-link" aria-describedby="r66">66</a>)). Among people living with CHC, we estimate that 58.5% were diagnosed, suggesting that Canada is close to meeting the 2025 diagnosis target of 60%. However, additional data will be needed to quantify awareness of CHC in all key populations. We identified 2.54 HCV-related deaths per 100,000 population, suggesting that Canada has met the 2025 target of 3 per 100,000. However, this finding contrasts with other evidence suggesting a seven per 100,000 population mortality rate in Canada for 2021 ((<a href="#r64" class="usa-link" aria-describedby="r64">64</a>)). Of note, in absolute numbers, more deaths were attributed to HCV than HBV in 2021, despite the availability of curative treatment which is associated with reduced mortality ((<a href="#r68" class="usa-link" aria-describedby="r68">68</a>)).Treatment data suggest that more people are being treated for HCV each year than there are new infections. Administrative data for key populations is not available at the national level, although it is documented that self-reported treatment uptake varies by key populations ((<a href="#r32" class="usa-link" aria-describedby="r32">32</a>,<a href="#r69" class="usa-link" aria-describedby="r69">69</a>)). Since treatment estimates do not consider mortality among treated individuals, we are unable to report on the proportion treated among people living with diagnosed HCV.</p>
<section id="sec30"><h3 class="pmc_sec_title">Limitations</h3>
<p>The main strengths of this study are the use of updated Canadian Health Measures Survey (CHMS) data, in combination with results from modelling using national surveillance data as model inputs for the first national HBV estimates and updated HCV estimates. We also compiled a thorough list of relevant scientific studies to inform the workbook estimates.</p>
<p>The analyses for this study have several limitations. First, mathematical modelling used for incidence (HCV) and as a lower bound for prevalence was based on reported cases, likely underestimating the true burden. The COVID-19 pandemic had an impact on STBBI testing in Canada ((<a href="#r70" class="usa-link" aria-describedby="r70">70</a>–<a href="#r73" class="usa-link" aria-describedby="r73">73</a>)), potentially making the modelled estimates for 2020–2021 an underestimation despite mathematical corrections. The workbook method produces large ranges of uncertainty given the heterogeneity of studies (e.g., participants, sampling, methods, geographic location) and data. In some instances, results from local studies were extrapolated nationally. These may impact the precision and accuracy of the estimates. Data is limited for key populations, restricting our capacity to provide estimates for all. Moreover, given the intersection of risks and identities across key populations, estimates cannot be added together or used to create proportions. The general population estimates for CHC rely on data for a reference period up to 2019, therefore this study’s findings may be more representative of the burden for 2019 than for the end of 2021. Measures of HBsAg and HCV RNA, where applicable, were used as proxies for CHB and CHC infections, respectively. Both could potentially result in a slightly overestimated chronicity, given that HBsAg is a marker of active HBV infection that occurs in its acute or chronic phase ((<a href="#r74" class="usa-link" aria-describedby="r74">74</a>)), and that HCV RNA is detectable for most people in the acute phase of the infection ((<a href="#r75" class="usa-link" aria-describedby="r75">75</a>)). The measure of the HBV vaccine target is likely overestimated since it is measured in adolescents with at least one dose. For mortality, a direct measurement method of documented causes of deaths was used, which excludes all deaths among undiagnosed individuals. As well, potential underreporting of causes on death certification is likely, which could lead to underestimation of the measure towards the target for deaths not identified as viral hepatitis-related. On the other hand, deaths with other direct causes, such as accidents or drug toxicity, may be misclassified as viral hepatitis-related, which would result in overestimation of mortality. Given the nature of this study, we could not control for confounding and missing data.</p></section></section><section id="sec31"><h2 class="pmc_sec_title">Conclusion</h2>
<p>Prevention of advanced liver disease caused by viral hepatitis is possible, and epidemiological estimates are essential to identify gaps in the care continuum by key population, contribute to planning evidence-based interventions, and track progress towards elimination as a public health concern. While these estimates suggest that Canada has met or is on track to meet six of the 15 global targets for 2025, more work is needed to address data gaps and to meet the targets that are not on track, such as HCV incidence. Additional national-level data are needed to produce estimates of prevalence and proportion unaware among all key population and to report Canada’s progress towards all elimination targets, including validated treatment data for HBV and cascade of care data.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank non-co-author members of our Working Group for their expert guidance throughout the estimates process: Drs Carla S. Coffin, Brian Conway, Naveed Janjua, Curtis Cooper, Christina Greenaway, Gisela Macphail, Sara Larney, Samuel S. Lee, William W.L. Wong, Marjolaine Pruvost, Abdel Aziz Shaheen and Eliverta Bicja. We also thank Correctional Service Canada, Alberta Health Services, and teams for the Tracks bio-behavioural surveys (Public Health Agency of Canada), the Virtual Cascade of Care Cohort, the Hepatitis cohort (HEPCO) and the Engage cohort for sharing unpublished data. We thank the health librarians from the Health Canada Library for providing the systematic literature searches.</p></section><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2">
<p>Competing interests</p>
<p>The statements, findings, conclusions, views, and opinions expressed in this report are based in part on data obtained under licence from IQVIA Solutions Canada Inc. concerning the following information service(s): CompuScript and GPM Custom Solutions from January 2012 to December 2021. All Rights Reserved. The statements, findings, conclusions, views, and opinions expressed herein are not necessarily those of IQVIA Solutions Canada Inc. or any of its affiliated or subsidiary entities.</p>
<p>MJB reports receiving presentation fees from AbbVie and Gilead, and grant funding from AbbVie, Gilead, and Cepheid. NK has received research funding from ViiV Healthcare, Abbvie, and Gilead, advisory fees from Gilead Sciences, ViiV Healthcare, Merck, and Abbvie, and speaker fees from Gilead Sciences, Abbvie, and Merck, all outside this work. MBK reports grants for investigator-initiated studies from ViiV Healthcare, AbbVie, and Gilead; and consulting fees from ViiV Healthcare, Merck, AbbVie, and Gilead.</p>
</div></div></section><section id="fn-group2" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn3">
<p>Funding</p>
<p>This work was supported by the Public Health Agency of Canada. MBK is supported by a Tier I Canada Research Chair. NK is supported by a career award from the <em>Fonds de Recherche Québec – Santé (FRQ-S; Junior 2).</em></p>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="r1">
<span class="label">1.</span><cite>World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva, CH: WHO; 2021. <a href="https://www.who.int/publications/i/item/9789240027077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/9789240027077</a></cite>
</li>
<li id="r2">
<span class="label">2.</span><cite>Paccoud O, Surgers L, Lacombe K. [Hepatitis B virus infection: natural history, clinical manifestations and therapeutic approach]. Rev Med Interne
2019;40(9):590–8. 10.1016/j.revmed.2019.03.333
</cite> [<a href="https://doi.org/10.1016/j.revmed.2019.03.333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30982550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Med%20Interne&amp;title=%5BHepatitis%20B%20virus%20infection:%20natural%20history,%20clinical%20manifestations%20and%20therapeutic%20approach%5D&amp;volume=40&amp;issue=9&amp;publication_year=2019&amp;pages=590-8&amp;pmid=30982550&amp;doi=10.1016/j.revmed.2019.03.333&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r3">
<span class="label">3.</span><cite>World Health Organization. Global hepatitis report 2024: Action for access in low- and middle-income countries. Geneva, CH: WHO; 2024. <a href="https://www.who.int/publications/i/item/9789240091672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/9789240091672</a></cite>
</li>
<li id="r4">
<span class="label">4.</span><cite>Yau AH, Marquez-Azalgara V, Yoshida EM. Hepatitis C (chronic). BMJ Clin Evid 2015:0921. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4479184/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pmc.ncbi.nlm.nih.gov/articles/PMC4479184/</a></cite> [<a href="/articles/PMC4479184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26107930/" class="usa-link">PubMed</a>]</li>
<li id="r5">
<span class="label">5.</span><cite>Asselah T, Marcellin P, Schinazi RF. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?
Liver Int
2018;38(Suppl 1
Suppl 1):7–13. 10.1111/liv.13673
</cite> [<a href="https://doi.org/10.1111/liv.13673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7713514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29427484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Treatment%20of%20hepatitis%20C%20virus%20infection%20with%20direct-acting%20antiviral%20agents:%20100%%20cure?&amp;volume=38&amp;issue=Suppl%201&amp;publication_year=2018&amp;pages=7-13&amp;pmid=29427484&amp;doi=10.1111/liv.13673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r6">
<span class="label">6.</span><cite>Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, Smyth D, Feld JJ; Canadian Association for the Study of the Liver . The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. CMAJ
2018;190(22):E677–87. 10.1503/cmaj.170453
</cite> [<a href="https://doi.org/10.1503/cmaj.170453" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5988519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29866893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=The%20management%20of%20chronic%20hepatitis%20C:%202018%20guideline%20update%20from%20the%20Canadian%20Association%20for%20the%20Study%20of%20the%20Liver&amp;volume=190&amp;issue=22&amp;publication_year=2018&amp;pages=E677-87&amp;pmid=29866893&amp;doi=10.1503/cmaj.170453&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r7">
<span class="label">7.</span><cite>Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups. Blueprint to inform hepatitis C elimination efforts in Canada. Toronto, ON: CanHepC; 2019. <a href="https://www.canhepc.ca/en/blueprint" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canhepc.ca/en/blueprint</a></cite>
</li>
<li id="r8">
<span class="label">8.</span><cite>Public Health Agency of Canada. Government of Canada’s Sexually transmitted and blood-borne infections (STBBI) Action plan 2024-2030. Ottawa, ON: PHAC; 2024. <a href="https://www.canada.ca/en/public-health/services/publications/diseases-conditions/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/publications/diseases-conditions/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html</a></cite>
</li>
<li id="r9">
<span class="label">9.</span><cite>Public Health Agency of Canada. Reducing the health impact of sexually transmitted and blood-borne infections in Canada by 2030: A pan-Canadian STBBI framework for action. Ottawa, ON: PHAC; 2018. <a href="https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/reports-publications/sexually-transmitted-blood-borne-infections-action-framework.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/reports-publications/sexually-transmitted-blood-borne-infections-action-framework.html</a></cite>
</li>
<li id="r10">
<span class="label">10.</span><cite>Ontario Hepatitis C Elimination Planning Group, Advisory Committee and Working Groups. The Ontario Hepatitis C Elimination Roadmap. 2023. <a href="https://endhepc.ca/wp-content/uploads/2023/03/Ontario-Hepatitis-C-Elimination-Roadmap-Full-Report-in-English.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://endhepc.ca/wp-content/uploads/2023/03/Ontario-Hepatitis-C-Elimination-Roadmap-Full-Report-in-English.pdf</a></cite>
</li>
<li id="r11">
<span class="label">11.</span><cite>World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva, CH: WHO; 2022. <a href="https://www.who.int/publications/i/item/9789240053779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/publications/i/item/9789240053779</a></cite>
</li>
<li id="r12">
<span class="label">12.</span><cite>Statistics Canada. Population estimates on July 1, by age and gender, 2001–2023. Ottawa, ON: StatCan; 2024. <a href="https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501&amp;request_locale=en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501&amp;request_locale=en</a></cite>
</li>
<li id="r13">
<span class="label">13.</span><cite>Popovic N, Williams A, Périnet S, Campeau L, Yang Q, Zhang F, Yan P, Feld J, Janjua N, Klein M, Krajden M, Wong W, Cox J. National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Can Commun Dis Rep
2022;48(11-12):540–9. 10.14745/ccdr.v48i1112a07
</cite> [<a href="https://doi.org/10.14745/ccdr.v48i1112a07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10786238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38222827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=National%20Hepatitis%20C%20estimates:%20Incidence,%20prevalence,%20undiagnosed%20proportion%20and%20treatment,%20Canada,%202019&amp;volume=48&amp;issue=11-12&amp;publication_year=2022&amp;pages=540-9&amp;pmid=38222827&amp;doi=10.14745/ccdr.v48i1112a07&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r14">
<span class="label">14.</span><cite>Smith-Roberge J, Forouzannia F, Hamadeh A, Feng Z, Popovic N, Wong WW. A Mathematical Framework to Estimate Chronic Hepatitis B Prevalence and Undiagnosed Proportion.
JMIR Preprints
2024:66309. 10.2196/preprints.66309</cite> [<a href="https://doi.org/10.2196/preprints.66309" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12367349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40835390/" class="usa-link">PubMed</a>]</li>
<li id="r15">
<span class="label">15.</span><cite>Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med
1998;17(8):857–72. 
</cite> [<a href="https://doi.org/10.1002/(SICI)1097-0258(19980430)17:8&amp;#x0003c;857::AID-SIM777&amp;#x0003e;3.0.CO;2-E" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9595616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stat%20Med&amp;title=Two-sided%20confidence%20intervals%20for%20the%20single%20proportion:%20comparison%20of%20seven%20methods&amp;volume=17&amp;issue=8&amp;publication_year=1998&amp;pages=857-72&amp;pmid=9595616&amp;doi=10.1002/(SICI)1097-0258(19980430)17:8&amp;#x0003c;857::AID-SIM777&amp;#x0003e;3.0.CO;2-E&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r16">
<span class="label">16.</span><cite>Statistics Canada. Table 17-10-0016-01: Estimates of births, by gender, annual. Ottawa, ON: StatCan; 2024. <a href="https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710001601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710001601</a></cite>
</li>
<li id="r17">
<span class="label">17.</span><cite>Public Health Agency of Canada. Highlights from the 2021 childhood National Immunization Coverage Survey (cNICS). Ottawa, ON: PHAC; 2024. <a href="https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/2021-highlights-childhood-national-immunization-coverage-survey.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/2021-highlights-childhood-national-immunization-coverage-survey.html</a></cite>
</li>
<li id="r18">
<span class="label">18.</span><cite>Statistics Canada. Statistics Canada, Canadian Vital Statistics - Death database (CVSD). Ottawa, ON: StatCan; 2024. <a href="https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&amp;SDDS=3233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&amp;SDDS=3233</a></cite>
</li>
<li id="r19">
<span class="label">19.</span><cite>Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. Can Commun Dis Rep
2014;40(19):429–36. 10.14745/ccdr.v40i19a02
</cite> [<a href="https://doi.org/10.14745/ccdr.v40i19a02" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5864479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29769874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Estimated%20prevalence%20of%20Hepatitis%20C%20Virus%20infection%20in%20Canada,%202011&amp;volume=40&amp;issue=19&amp;publication_year=2014&amp;pages=429-36&amp;pmid=29769874&amp;doi=10.14745/ccdr.v40i19a02&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r20">
<span class="label">20.</span><cite>Hansen PC, Pereyra V, Scherer G. Least Squares Data Fitting with Applications: Johns Hopkins University Press; 2013.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hansen%20PC,%20Pereyra%20V,%20Scherer%20G.%20Least%20Squares%20Data%20Fitting%20with%20Applications:%20Johns%20Hopkins%20University%20Press;%202013." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r21">
<span class="label">21.</span><cite>Périnet S, Williams A, Yang Q, Campeau L, Day J, Lamboo L, Lee ER, Osiowy C, Popovic N. Prevalence and awareness of hepatitis B and hepatitis C and vaccine-induced immunity to hepatitis B: Findings from the Canadian Health Measure Survey, 2016–2019. Can Commun Dis Rep
2025;51(6/7):238–48. 10.14745/ccdr.v51i67a03</cite> [<a href="https://doi.org/10.14745/ccdr.v51i67a03" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Prevalence%20and%20awareness%20of%20hepatitis%20B%20and%20hepatitis%20C%20and%20vaccine-induced%20immunity%20to%20hepatitis%20B:%20Findings%20from%20the%20Canadian%20Health%20Measure%20Survey,%202016%E2%80%932019&amp;volume=51&amp;issue=6/7&amp;publication_year=2025&amp;pages=238-48&amp;doi=10.14745/ccdr.v51i67a03&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r22">
<span class="label">22.</span><cite>Biondi MJ, Marchand-Austin A, Cronin K, Nanwa N, Ravirajan V, Mandel E, Goneau LW, Mazzulli T, Shah H, Capraru C, Janssen HL, Sander B, Feld JJ. Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study. CMAJ
2020;192(43):E1299–305. 10.1503/cmaj.200290
</cite> [<a href="https://doi.org/10.1503/cmaj.200290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7577574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33106301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=Prenatal%20hepatitis%20B%20screening,%20and%20hepatitis%20B%20burden%20among%20children,%20in%20Ontario:%20a%20descriptive%20study&amp;volume=192&amp;issue=43&amp;publication_year=2020&amp;pages=E1299-305&amp;pmid=33106301&amp;doi=10.1503/cmaj.200290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r23">
<span class="label">23.</span><cite>Adeleye AO, Plitt SS, Douglas L, Charlton CL. Overview of a Provincial Prenatal Communicable Disease Screening Program: 2002-2016. J Obstet Gynaecol Can
2020;42(3):269–76. 10.1016/j.jogc.2019.05.013
</cite> [<a href="https://doi.org/10.1016/j.jogc.2019.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31447401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Obstet%20Gynaecol%20Can&amp;title=Overview%20of%20a%20Provincial%20Prenatal%20Communicable%20Disease%20Screening%20Program:%202002-2016&amp;volume=42&amp;issue=3&amp;publication_year=2020&amp;pages=269-76&amp;pmid=31447401&amp;doi=10.1016/j.jogc.2019.05.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r24">
<span class="label">24.</span><cite>Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. World J Gastroenterol
2018;24(11):1216–27. 10.3748/wjg.v24.i11.1216
</cite> [<a href="https://doi.org/10.3748/wjg.v24.i11.1216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5859224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29568202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Gastroenterol&amp;title=Differing%20profiles%20of%20people%20diagnosed%20with%20acute%20and%20chronic%20hepatitis%20B%20virus%20infection%20in%20British%20Columbia,%20Canada&amp;volume=24&amp;issue=11&amp;publication_year=2018&amp;pages=1216-27&amp;pmid=29568202&amp;doi=10.3748/wjg.v24.i11.1216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r25">
<span class="label">25.</span><cite>Campeau L, Elliott J, Williams A, Périnet S, Yang Q, Cox J, Feld JJ, Greenaway C, Popovic N. Estimated prevalence of hepatitis B and C among immigrants in Canada. Can Commun Dis Rep
2025;51(6/7):214–22. 10.14745/ccdr.v51i67a01</cite> [<a href="https://doi.org/10.14745/ccdr.v51i67a01" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Estimated%20prevalence%20of%20hepatitis%20B%20and%20C%20among%20immigrants%20in%20Canada&amp;volume=51&amp;issue=6/7&amp;publication_year=2025&amp;pages=214-22&amp;doi=10.14745/ccdr.v51i67a01&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r26">
<span class="label">26.</span><cite>Yasseen AS, Kwong JC, Feld JJ, Kustra R, MacDonald L, Greenaway CC, Janjua NZ, Mazzulli T, Sherman M, Lapointe-Shaw L, Sander B, Crowcroft NS. The viral hepatitis B care cascade: A population-based comparison of immigrant groups. Hepatology
2022;75(3):673–89. 10.1002/hep.32162
</cite> [<a href="https://doi.org/10.1002/hep.32162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34537985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The%20viral%20hepatitis%20B%20care%20cascade:%20A%20population-based%20comparison%20of%20immigrant%20groups&amp;volume=75&amp;issue=3&amp;publication_year=2022&amp;pages=673-89&amp;pmid=34537985&amp;doi=10.1002/hep.32162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r27">
<span class="label">27.</span><cite>Sorge J, Colyer S, Cox J, Kroch A, Lachowsky N, Popovic N, Yang Q. Estimation of the population size of gay, bisexual and other men who have sex with men in Canada, 2020. Can Commun Dis Rep
2023;49(11-12):465–76. 10.14745/ccdr.v49i1112a02
</cite> [<a href="https://doi.org/10.14745/ccdr.v49i1112a02" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10946585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38504876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Estimation%20of%20the%20population%20size%20of%20gay,%20bisexual%20and%20other%20men%20who%20have%20sex%20with%20men%20in%20Canada,%202020&amp;volume=49&amp;issue=11-12&amp;publication_year=2023&amp;pages=465-76&amp;pmid=38504876&amp;doi=10.14745/ccdr.v49i1112a02&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r28">
<span class="label">28.</span><cite>Thompson KA, Blank G, Toy J, Moore DM, Lachowsky N, Bacani N, Zhang W, Sereda P, Lima VD, Barrios R, Montaner JS, Hull MW. Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada. Open Forum Infect Dis
2021;8(11):ofab492. 10.1093/ofid/ofab492
</cite> [<a href="https://doi.org/10.1093/ofid/ofab492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8598915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34805433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Forum%20Infect%20Dis&amp;title=Chronic%20Hepatitis%20B%20Infection%20Among%20Preexposure%20Prophylaxis%20Users%20Enrolled%20in%20a%20Population-Based%20Program%20in%20British%20Columbia,%20Canada&amp;volume=8&amp;issue=11&amp;publication_year=2021&amp;pages=ofab492&amp;pmid=34805433&amp;doi=10.1093/ofid/ofab492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r29">
<span class="label">29.</span><cite>Yasseen AS 3rd, Kwong JC, Feld JJ, Janjua NZ, Greenaway C, Lapointe-Shaw L, Sherman M, Mazzulli T, Kustra R, MacDonald L, Sander B, Crowcroft NS. Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents. Liver Int
2021;41(8):1775–88. 10.1111/liv.14840
</cite> [<a href="https://doi.org/10.1111/liv.14840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33655665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Viral%20hepatitis%20C%20cascade%20of%20care:%20A%20population-level%20comparison%20of%20immigrant%20and%20long-term%20residents&amp;volume=41&amp;issue=8&amp;publication_year=2021&amp;pages=1775-88&amp;pmid=33655665&amp;doi=10.1111/liv.14840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r30">
<span class="label">30.</span><cite>Bartlett SR, Yu A, Chapinal N, Rossi C, Butt Z, Wong S, Darvishian M, Gilbert M, Wong J, Binka M, Alvarez M, Tyndall M, Krajden M, Janjua NZ. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals. Liver Int
2019;39(12):2261–72. 10.1111/liv.14227
</cite> [<a href="https://doi.org/10.1111/liv.14227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31444846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=The%20population%20level%20care%20cascade%20for%20hepatitis%20C%20in%20British%20Columbia,%20Canada%20as%20of%202018:%20impact%20of%20direct%20acting%20antivirals&amp;volume=39&amp;issue=12&amp;publication_year=2019&amp;pages=2261-72&amp;pmid=31444846&amp;doi=10.1111/liv.14227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r31">
<span class="label">31.</span><cite>Vanderhoff A, Smookler D, Biondi MJ, Enman S, Fuliang T, Mahmood S, Crespi A, Marquez M, Van Uum R, You L, Wolfson-Stofko B, Logan R, LeDrew E, Shah H, Janssen H, Capraru C, Venier E, Feld JJ. Leveraging COVID-19 vaccination to promote hepatitis C screening. Hepatol Commun
2022;7(1):e2101. 10.1002/hep4.2101
</cite> [<a href="https://doi.org/10.1002/hep4.2101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9827963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36329631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatol%20Commun&amp;title=Leveraging%20COVID-19%20vaccination%20to%20promote%20hepatitis%20C%20screening&amp;volume=7&amp;issue=1&amp;publication_year=2022&amp;pages=e2101&amp;pmid=36329631&amp;doi=10.1002/hep4.2101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r32">
<span class="label">32.</span><cite>Tarasuk J, Zhang J, Lemyre A, Cholette F, Bryson M, Paquette D. National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019. Can Commun Dis Rep
2020;46(5):138–48. 10.14745/ccdr.v46i05a07
</cite> [<a href="https://doi.org/10.14745/ccdr.v46i05a07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8868043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35283692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=National%20findings%20from%20the%20Tracks%20survey%20of%20people%20who%20inject%20drugs%20in%20Canada,%20Phase%204,%202017-2019&amp;volume=46&amp;issue=5&amp;publication_year=2020&amp;pages=138-48&amp;pmid=35283692&amp;doi=10.14745/ccdr.v46i05a07&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r33">
<span class="label">33.</span><cite>Selfridge M, Barnett T, Lundgren K, Guarasci K, Milne R, Drost A, Fraser C. Treating people where they are: nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada. Public Health Nurs
2022;39(5):1009–16. 10.1111/phn.13092
</cite> [<a href="https://doi.org/10.1111/phn.13092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35537120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Public%20Health%20Nurs&amp;title=Treating%20people%20where%20they%20are:%20nurse-led%20micro-elimination%20of%20hepatitis%20C%20in%20supported%20housing%20sites%20for%20networks%20of%20people%20who%20inject%20drugs%20in%20Victoria,%20Canada&amp;volume=39&amp;issue=5&amp;publication_year=2022&amp;pages=1009-16&amp;pmid=35537120&amp;doi=10.1111/phn.13092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r34">
<span class="label">34.</span><cite>Lettner B, Mason K, Greenwald ZR, Broad J, Mandel E, Feld JJ, Powis J. Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study. Lancet Reg Health Am
2023;22:100490. 10.1016/j.lana.2023.100490
</cite> [<a href="https://doi.org/10.1016/j.lana.2023.100490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10300568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37388709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Reg%20Health%20Am&amp;title=Rapid%20hepatitis%20C%20virus%20point-of-care%20RNA%20testing%20and%20treatment%20at%20an%20integrated%20supervised%20consumption%20service%20in%20Toronto,%20Canada:%20a%20prospective,%20observational%20cohort%20study&amp;volume=22&amp;publication_year=2023&amp;pages=100490&amp;pmid=37388709&amp;doi=10.1016/j.lana.2023.100490&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r35">
<span class="label">35.</span><cite>Williams A, Sorge J, Périnet S, Yang Q, Cox J, Bonn M, Smoke A, Popovic N. Estimating the population size of people who inject drugs in Canada.  Can Commun Dis Rep  2025; Upcoming.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Estimating%20the%20population%20size%20of%20people%20who%20inject%20drugs%20in%20Canada.&amp;pages=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r36">
<span class="label">36.</span><cite>Biondi MJ, Hirode G, Capraru C, Vanderhoff A, Karkada J, Wolfson-Stofko B, Smookler D, Friedman SM, Bates K, Mazzulli T, Juan JV, Shah H, Hansen BE, Feld JJ, Janssen H. Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario. Can Liver J
2022;5(3):362–71. 10.3138/canlivj-2021-0036
</cite> [<a href="https://doi.org/10.3138/canlivj-2021-0036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9473558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36133900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Liver%20J&amp;title=Birth%20cohort%20hepatitis%20C%20antibody%20prevalence%20in%20real-world%20screening%20settings%20in%20Ontario&amp;volume=5&amp;issue=3&amp;publication_year=2022&amp;pages=362-71&amp;pmid=36133900&amp;doi=10.3138/canlivj-2021-0036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r37">
<span class="label">37.</span><cite>Broad J, Mason K, Guyton M, Lettner B, Matelski J, Powis J. Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada. Int J Drug Policy
2020;80:102755. 10.1016/j.drugpo.2020.102755
</cite> [<a href="https://doi.org/10.1016/j.drugpo.2020.102755" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32416538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Drug%20Policy&amp;title=Peer%20outreach%20point-of-care%20testing%20as%20a%20bridge%20to%20hepatitis%20C%20care%20for%20people%20who%20inject%20drugs%20in%20Toronto,%20Canada&amp;volume=80&amp;publication_year=2020&amp;pages=102755&amp;pmid=32416538&amp;doi=10.1016/j.drugpo.2020.102755&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r38">
<span class="label">38.</span><cite>Barnett T, Selfridge M, Mundo L, Johnson S, Drost A, Guarasci K, Lundgren K, Fraser C. Collaborating with prison to test and treat people who use drugs in Victoria, British Columbia. Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2024; February 27–March 3 2024; University of Toronto Press; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?Barnett%20T,%20Selfridge%20M,%20Mundo%20L,%20Johnson%20S,%20Drost%20A,%20Guarasci%20K,%20Lundgren%20K,%20Fraser%20C.%20Collaborating%20with%20prison%20to%20test%20and%20treat%20people%20who%20use%20drugs%20in%20Victoria,%20British%20Columbia.%20Annual%20Meeting%20of%20the%20Canadian%20Association%20for%20the%20Study%20of%20the%20Liver%20(CASL),%20the%20Canadian%20Network%20on%20Hepatitis%20C%20(CANHEPC)%20and%20the%20Canadian%20Association%20of%20Hepatology%20Nurses%20(CAHN)%202024;%20February%2027%E2%80%93March%203%202024;%20University%20of%20Toronto%20Press;%202024." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r39">
<span class="label">39.</span><cite>Courtemanche Y, Poulin C, Serhir B, Alary M. HIV and hepatitis C virus infections in Quebec’s provincial detention centres: comparing prevalence and related risky behaviours between 2003 and 2014-2015. Can J Public Health
2018;109(3):353–61. 10.17269/s41997-018-0047-4
</cite> [<a href="https://doi.org/10.17269/s41997-018-0047-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6964431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29981093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20J%20Public%20Health&amp;title=HIV%20and%20hepatitis%20C%20virus%20infections%20in%20Quebec%E2%80%99s%20provincial%20detention%20centres:%20comparing%20prevalence%20and%20related%20risky%20behaviours%20between%202003%20and%202014-2015&amp;volume=109&amp;issue=3&amp;publication_year=2018&amp;pages=353-61&amp;pmid=29981093&amp;doi=10.17269/s41997-018-0047-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r40">
<span class="label">40.</span><cite>Kronfli N, Dussault C, Klein MB, Lebouché B, Sebastiani G, Cox J. The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort study. CMAJ Open
2019;7(4):E674–9. 10.9778/cmajo.20190068
</cite> [<a href="https://doi.org/10.9778/cmajo.20190068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6890491/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31796509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ%20Open&amp;title=The%20hepatitis%20C%20virus%20cascade%20of%20care%20in%20a%20Quebec%20provincial%20prison:%20a%20retrospective%20cohort%20study&amp;volume=7&amp;issue=4&amp;publication_year=2019&amp;pages=E674-9&amp;pmid=31796509&amp;doi=10.9778/cmajo.20190068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r41">
<span class="label">41.</span><cite>Statistics Canada. Table 35-10-0154-01: Average counts of adults in provincial and territorial correctional programs. Ottawa, ON: StatCan; 2024. <a href="https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=3510015401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=3510015401</a></cite>
</li>
<li id="r42">
<span class="label">42.</span><cite>Lydon-Hassen K, Jonah L, Mayotte L, Hrabowy A, Graham B, Missens B, Nelson A, Andkhoie M, Nahachewsky D, Yalamanchili DT, Gupta S, Ndubuka N, Khan I, Yacoub W, Bryson M, Paquette D. Summary findings from Tracks surveys implemented by First Nations in Saskatchewan and Alberta, Canada, 2018-2020. Can Commun Dis Rep
2022;48(4):146–56. 10.14745/ccdr.v48i04a05
</cite> [<a href="https://doi.org/10.14745/ccdr.v48i04a05" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9017804/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35480707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Summary%20findings%20from%20Tracks%20surveys%20implemented%20by%20First%20Nations%20in%20Saskatchewan%20and%20Alberta,%20Canada,%202018-2020&amp;volume=48&amp;issue=4&amp;publication_year=2022&amp;pages=146-56&amp;pmid=35480707&amp;doi=10.14745/ccdr.v48i04a05&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r43">
<span class="label">43.</span><cite>Mendlowitz AB, Bremner KE, Krahn M, Walker JD, Wong WW, Sander B, Jones L, Isaranuwatchai W, Feld JJ. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study. CMAJ
2023;195(14):E499–512. 10.1503/cmaj.220717
</cite> [<a href="https://doi.org/10.1503/cmaj.220717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10089629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37040993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ&amp;title=Characterizing%20the%20cascade%20of%20care%20for%20hepatitis%20C%20virus%20infection%20among%20Status%20First%20Nations%20peoples%20in%20Ontario:%20a%20retrospective%20cohort%20study&amp;volume=195&amp;issue=14&amp;publication_year=2023&amp;pages=E499-512&amp;pmid=37040993&amp;doi=10.1503/cmaj.220717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r44">
<span class="label">44.</span><cite>Statistics Canada. Table 98-10-0292-01: Indigenous identity population by gender and age: Canada, provinces and territories, census metropolitan areas and census agglomerations. Ottawa, ON: StatCan; 2024. <a href="https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=9810029201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=9810029201</a></cite>
</li>
<li id="r45">
<span class="label">45.</span><cite>Thompson KA, Blank G, Toy J, Moore DM, Lachowsky N, Bacani N, Zhang W, Sereda P, Lima VD, Barrios R, Montaner JS, Hull MW. Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada. Liver Int
2022;42(7):1528–35. 10.1111/liv.15237
</cite> [<a href="https://doi.org/10.1111/liv.15237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35274805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Prevalence%20and%20incidence%20of%20hepatitis%20C%20infection%20amongst%20men%20who%20have%20sex%20with%20men%20in%20a%20population-based%20pre-exposure%20prophylaxis%20program%20in%20British%20Columbia,%20Canada&amp;volume=42&amp;issue=7&amp;publication_year=2022&amp;pages=1528-35&amp;pmid=35274805&amp;doi=10.1111/liv.15237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r46">
<span class="label">46.</span><cite>Tabatabavakili S, Aleyadeh W, Cerrocchi O, Janssen HL, Hansen BE, Bogoch II, Feld JJ; Viral Hepatitis Care Network Investigators . Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis. Clin Gastroenterol Hepatol
2022;20(3):674–81. 10.1016/j.cgh.2021.03.006
</cite> [<a href="https://doi.org/10.1016/j.cgh.2021.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33737225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Gastroenterol%20Hepatol&amp;title=Incidence%20of%20Hepatitis%20C%20Virus%20Infections%20Among%20Users%20of%20Human%20Immunodeficiency%20Virus%20Pre-exposure%20Prophylaxis&amp;volume=20&amp;issue=3&amp;publication_year=2022&amp;pages=674-81&amp;pmid=33737225&amp;doi=10.1016/j.cgh.2021.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r47">
<span class="label">47.</span><cite>Bolotin S, Feld JJ, Garber G, Wong WW, Guerra FM, Mazzulli T. Population-based estimate of hepatitis C virus prevalence in Ontario, Canada. PLoS One
2018;13(1):e0191184. 10.1371/journal.pone.0191184
</cite> [<a href="https://doi.org/10.1371/journal.pone.0191184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5779675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29360823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Population-based%20estimate%20of%20hepatitis%20C%20virus%20prevalence%20in%20Ontario,%20Canada&amp;volume=13&amp;issue=1&amp;publication_year=2018&amp;pages=e0191184&amp;pmid=29360823&amp;doi=10.1371/journal.pone.0191184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r48">
<span class="label">48.</span><cite>Forouzannia F, Hamadeh A, Passos-Castilho AM, Erman A, Yu A, Feng Z, Janjua NZ, Sander B, Greenaway C, Wong WW. Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver Int
2024;44(6):1383–95. 10.1111/liv.15875
</cite> [<a href="https://doi.org/10.1111/liv.15875" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38445848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Impact%20of%20new%20direct-acting%20antiviral%20therapy%20on%20the%20prevalence%20and%20undiagnosed%20proportion%20of%20chronic%20hepatitis%20C%20infection&amp;volume=44&amp;issue=6&amp;publication_year=2024&amp;pages=1383-95&amp;pmid=38445848&amp;doi=10.1111/liv.15875&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r49">
<span class="label">49.</span><cite>Forouzannia F, Eze N, Clement F, Wong W. The impact of new DAA therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection in Alberta: a model-based analysis. Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2024; February 27–March 3 2024; University of Toronto Press; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?Forouzannia%20F,%20Eze%20N,%20Clement%20F,%20Wong%20W.%20The%20impact%20of%20new%20DAA%20therapy%20on%20the%20prevalence%20and%20undiagnosed%20proportion%20of%20chronic%20hepatitis%20C%20infection%20in%20Alberta:%20a%20model-based%20analysis.%20Annual%20Meeting%20of%20the%20Canadian%20Association%20for%20the%20Study%20of%20the%20Liver%20(CASL),%20the%20Canadian%20Network%20on%20Hepatitis%20C%20(CANHEPC)%20and%20the%20Canadian%20Association%20of%20Hepatology%20Nurses%20(CAHN)%202024;%20February%2027%E2%80%93March%203%202024;%20University%20of%20Toronto%20Press;%202024." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r50">
<span class="label">50.</span><cite>Pearce ME, Bartlett SR, Yu A, Lamb J, Reitz C, Wong S, Alvarez M, Binka M, Velásquez Garcia H, Jeong D, Clementi E, Adu P, Samji H, Wong J, Buxton J, Yoshida E, Elwood C, Sauve L, Pick N, Krajden M, Janjua NZ. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study. BMC Womens Health
2021;21(1):330. 10.1186/s12905-021-01470-7
</cite> [<a href="https://doi.org/10.1186/s12905-021-01470-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8436483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34511082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Womens%20Health&amp;title=Women%20in%20the%202019%20hepatitis%20C%20cascade%20of%20care:%20findings%20from%20the%20British%20Columbia%20Hepatitis%20Testers%20cohort%20study&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=330&amp;pmid=34511082&amp;doi=10.1186/s12905-021-01470-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r51">
<span class="label">51.</span><cite>Binka M, Janjua NZ, Grebely J, Estes C, Schanzer D, Kwon JA, Shoukry NH, Kwong JC, Razavi H, Feld JJ, Krajden M. Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model. JAMA Netw Open
2020;3(5):e204192. 10.1001/jamanetworkopen.2020.4192
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2020.4192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7203608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32374397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Assessment%20of%20Treatment%20Strategies%20to%20Achieve%20Hepatitis%20C%20Elimination%20in%20Canada%20Using%20a%20Validated%20Model&amp;volume=3&amp;issue=5&amp;publication_year=2020&amp;pages=e204192&amp;pmid=32374397&amp;doi=10.1001/jamanetworkopen.2020.4192&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r52">
<span class="label">52.</span><cite>Hamadeh A, Feng Z, Krahn M, Wong WW. A model-based framework for chronic hepatitis C prevalence estimation. PLoS One
2019;14(11):e0225366. 10.1371/journal.pone.0225366
</cite> [<a href="https://doi.org/10.1371/journal.pone.0225366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6874092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31751393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=A%20model-based%20framework%20for%20chronic%20hepatitis%20C%20prevalence%20estimation&amp;volume=14&amp;issue=11&amp;publication_year=2019&amp;pages=e0225366&amp;pmid=31751393&amp;doi=10.1371/journal.pone.0225366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r53">
<span class="label">53.</span><cite>Greenwald ZR, Bouck Z, McLean E, Mason K, Lettner B, Broad J. Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: a cross-sectional analysis. J Viral Hepat
2022.. 
10.1111/jvh.13780
</cite> [<a href="https://doi.org/10.1111/jvh.13780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36461705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Viral%20Hepat&amp;title=Integrated%20supervised%20consumption%20services%20and%20hepatitis%20C%20testing%20and%20treatment%20among%20people%20who%20inject%20drugs%20in%20Toronto,%20Canada:%20a%20cross-sectional%20analysis&amp;publication_year=2022.&amp;pmid=36461705&amp;doi=10.1111/jvh.13780&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r54">
<span class="label">54.</span><cite>Hannigan A. Improving HCV Cascade of Care Among People Who Use Drugs: A Rapid Pilot Program Evaluation and Implication for Future Interventions. British Columbia Centre for Excellence in HIV/AIDS 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hannigan%20A.%20Improving%20HCV%20Cascade%20of%20Care%20Among%20People%20Who%20Use%20Drugs:%20A%20Rapid%20Pilot%20Program%20Evaluation%20and%20Implication%20for%20Future%20Interventions.%20British%20Columbia%20Centre%20for%20Excellence%20in%20HIV/AIDS%202023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r55">
<span class="label">55.</span><cite>Mendlowitz A, Bremner KE, Walker JD, Wong WW, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis. CMAJ Open
2021;9(3):E886–96. 10.9778/cmajo.20200164
</cite> [<a href="https://doi.org/10.9778/cmajo.20200164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8486470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34584007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ%20Open&amp;title=Hepatitis%20C%20virus%20infection%20in%20First%20Nations%20populations%20in%20Ontario%20from%202006%20to%202014:%20a%20population-based%20retrospective%20cohort%20analysis&amp;volume=9&amp;issue=3&amp;publication_year=2021&amp;pages=E886-96&amp;pmid=34584007&amp;doi=10.9778/cmajo.20200164&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r56">
<span class="label">56.</span><cite>Smookler D, Beck A, Head B, Quoquat L, Albany C, Farrell T, Gordon J, Thurston N, You L, Capraru C, McKay M, Kim J, Feld JJ, Shah H. A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario. Can Liver J
2022;5(3):329–38. 10.3138/canlivj-2021-0031
</cite> [<a href="https://doi.org/10.3138/canlivj-2021-0031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9473560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36133895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Liver%20J&amp;title=A%20collaborative%20approach%20to%20hepatitis%20C%20testing%20in%20two%20First%20Nations%20communities%20of%20northwest%20Ontario&amp;volume=5&amp;issue=3&amp;publication_year=2022&amp;pages=329-38&amp;pmid=36133895&amp;doi=10.3138/canlivj-2021-0031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r57">
<span class="label">57.</span><cite>Rai M, Lowe C, Flemming JA. Screening for hepatitis C in an outpatient endoscopy unit. Can Liver J
2021;4(3):311–6. 10.3138/canlivj-2020-0038
</cite> [<a href="https://doi.org/10.3138/canlivj-2020-0038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9202776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35992259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Liver%20J&amp;title=Screening%20for%20hepatitis%20C%20in%20an%20outpatient%20endoscopy%20unit&amp;volume=4&amp;issue=3&amp;publication_year=2021&amp;pages=311-6&amp;pmid=35992259&amp;doi=10.3138/canlivj-2020-0038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r58">
<span class="label">58.</span><cite>Hamadeh A, Haines A, Feng Z, Thein HH, Janjua NZ, Krahn M, Wong WW. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies. J Viral Hepat
2020;27(12):1419–29. 10.1111/jvh.13373
</cite> [<a href="https://doi.org/10.1111/jvh.13373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32810886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Viral%20Hepat&amp;title=Estimating%20chronic%20hepatitis%20C%20prevalence%20in%20British%20Columbia%20and%20Ontario,%20Canada,%20using%20population-based%20cohort%20studies&amp;volume=27&amp;issue=12&amp;publication_year=2020&amp;pages=1419-29&amp;pmid=32810886&amp;doi=10.1111/jvh.13373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r59">
<span class="label">59.</span><cite>O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C. Canadian blood suppliers: an expanding role in public health surveillance?
Can Commun Dis Rep
2022;48(4):124–30. 10.14745/ccdr.v48i04a02
</cite> [<a href="https://doi.org/10.14745/ccdr.v48i04a02" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9017805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35480705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Commun%20Dis%20Rep&amp;title=Canadian%20blood%20suppliers:%20an%20expanding%20role%20in%20public%20health%20surveillance?&amp;volume=48&amp;issue=4&amp;publication_year=2022&amp;pages=124-30&amp;pmid=35480705&amp;doi=10.14745/ccdr.v48i04a02&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r60">
<span class="label">60.</span><cite>Public Health Agency of Canada. Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025. Ottawa, ON: PHAC; 2022. [Accessed 2024 July 1]. <a href="https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html</a></cite>
</li>
<li id="r61">
<span class="label">61.</span><cite>Rotermann M, Langlois K, Andonov A, Trubnikov M. Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey. Health Rep
2013;24(11):3–13.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/24259199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Health%20Rep&amp;title=Seroprevalence%20of%20hepatitis%20B%20and%20C%20virus%20infections:%20Results%20from%20the%202007%20to%202009%20and%202009%20to%202011%20Canadian%20Health%20Measures%20Survey&amp;volume=24&amp;issue=11&amp;publication_year=2013&amp;pages=3-13&amp;pmid=24259199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r62">
<span class="label">62.</span><cite>Polaris Observatory Collaborators . Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol
2023;8(10):879–907. 10.1016/S2468-1253(23)00197-8
</cite> [<a href="https://doi.org/10.1016/S2468-1253(23)00197-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37517414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Gastroenterol%20Hepatol&amp;title=Global%20prevalence,%20cascade%20of%20care,%20and%20prophylaxis%20coverage%20of%20hepatitis%20B%20in%202022:%20a%20modelling%20study&amp;volume=8&amp;issue=10&amp;publication_year=2023&amp;pages=879-907&amp;pmid=37517414&amp;doi=10.1016/S2468-1253(23)00197-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r63">
<span class="label">63.</span><cite>Biondi M, Marchand-Austin A, Mandel E, Goneau L, Mazzulli T, Janssen H. Prenatal HBsAg screening rates and follow-up DNA testing low in Ontario. Can Liver J
2019;2(2):90–1. 10.1503/cmaj.200290
</cite> [<a href="https://doi.org/10.1503/cmaj.200290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7577574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33106301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Liver%20J&amp;title=Prenatal%20HBsAg%20screening%20rates%20and%20follow-up%20DNA%20testing%20low%20in%20Ontario&amp;volume=2&amp;issue=2&amp;publication_year=2019&amp;pages=90-1&amp;pmid=33106301&amp;doi=10.1503/cmaj.200290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r64">
<span class="label">64.</span><cite>Institute for Health Metrics and Evaluation. GBD Results. Seattle, WA: IHME; 2021. [Accessed 2024 April 1]. <a href="https://vizhub.healthdata.org/gbd-results/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://vizhub.healthdata.org/gbd-results/</a></cite>
</li>
<li id="r65">
<span class="label">65.</span><cite>Public Health Agency of Canada. Hepatitis B vaccines: Canadian Immunization Guide. Ottawa, ON: PHAC; 2022. <a href="https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-7-hepatitis-b-vaccine.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-7-hepatitis-b-vaccine.html</a></cite>
</li>
<li id="r66">
<span class="label">66.</span><cite>O’Brien SF, Ehsani-Moghaddam B, Osmond L, Fan W, Goldman M, Drews SJ. Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: insight into a low-risk undiagnosed population. BMC Public Health
2024;24(1):2319. 10.1186/s12889-024-19790-2
</cite> [<a href="https://doi.org/10.1186/s12889-024-19790-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11348590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39192303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Public%20Health&amp;title=Epidemiology%20of%20Hepatitis%20C%20over%2028%20years%20of%20monitoring%20Canadian%20blood%20donors:%20insight%20into%20a%20low-risk%20undiagnosed%20population&amp;volume=24&amp;issue=1&amp;publication_year=2024&amp;pages=2319&amp;pmid=39192303&amp;doi=10.1186/s12889-024-19790-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r67">
<span class="label">67.</span><cite>The Polaris Observatory. Countries/Territories — Dashboard for Canada. 2024. <a href="https://cdafound.org/polaris-countries-dashboard/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cdafound.org/polaris-countries-dashboard/</a></cite>
</li>
<li id="r68">
<span class="label">68.</span><cite>Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D’Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S; French ANRS CO22 Hepather cohort . Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet
2019;393(10179):1453–64. 10.1016/S0140-6736(18)32111-1
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32111-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30765123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Clinical%20outcomes%20in%20patients%20with%20chronic%20hepatitis%20C%20after%20direct-acting%20antiviral%20treatment:%20a%20prospective%20cohort%20study&amp;volume=393&amp;issue=10179&amp;publication_year=2019&amp;pages=1453-64&amp;pmid=30765123&amp;doi=10.1016/S0140-6736(18)32111-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r69">
<span class="label">69.</span><cite>Lambert G, Apelian H, Tremblay C, Mbaye R, Pardoe W, Dvorakova M. Engage Montréal, Portrait de la santé sexuelle des hommes de la région métropolitaine de Montréal ayant des relations sexuelles avec des hommes, Cyle 2017-2018 Recueil de tableaux et outils. Direction générale de santé publique du CIUSSS du Centre-Sud-de-l’Île-de-Montréal. 2022. <a href="https://www.inspq.qc.ca/sites/default/files/documents/itss/engage_faitssaillants_mars-2019-b.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.inspq.qc.ca/sites/default/files/documents/itss/engage_faitssaillants_mars-2019-b.pdf</a></cite>
</li>
<li id="r70">
<span class="label">70.</span><cite>Mandel E, Peci A, Cronin K, Capraru CI, Shah H, Janssen HL, Tran V, Biondi MJ, Feld JJ. The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, Canada. J Viral Hepat
2022;29(3):205–8. 10.1111/jvh.13637
</cite> [<a href="https://doi.org/10.1111/jvh.13637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34820967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Viral%20Hepat&amp;title=The%20impact%20of%20the%20first,%20second%20and%20third%20waves%20of%20covid-19%20on%20hepatitis%20B%20and%20C%20testing%20in%20Ontario,%20Canada&amp;volume=29&amp;issue=3&amp;publication_year=2022&amp;pages=205-8&amp;pmid=34820967&amp;doi=10.1111/jvh.13637&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r71">
<span class="label">71.</span><cite>Binka M, Bartlett S, Velásquez García HA, Darvishian M, Jeong D, Adu P, Alvarez M, Wong S, Yu A, Samji H, Krajden M, Wong J, Janjua NZ. Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: an interrupted time series analysis. Liver Int
2021;41(12):2849–56. 10.1111/liv.15074
</cite> [<a href="https://doi.org/10.1111/liv.15074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8662267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34592046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Impact%20of%20COVID-19-related%20public%20health%20measures%20on%20HCV%20testing%20in%20British%20Columbia,%20Canada:%20an%20interrupted%20time%20series%20analysis&amp;volume=41&amp;issue=12&amp;publication_year=2021&amp;pages=2849-56&amp;pmid=34592046&amp;doi=10.1111/liv.15074&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r72">
<span class="label">72.</span><cite>Public Health Agency of Canada. Survey on the impact of COVID-19 on the delivery of STBBI prevention, testing and treatment, including harm reduction services, in Canada. Ottawa, ON: PHAC; 2021. <a href="https://www.canada.ca/en/public-health/services/publications/diseases-conditions/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.canada.ca/en/public-health/services/publications/diseases-conditions/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment.html</a></cite>
</li>
<li id="r73">
<span class="label">73.</span><cite>Kronfli N, Leone F, Dussault C, Miliani G, Gallant E, Potter M, Cox J. Impact of the COVID-19 pandemic on hepatitis C virus screening in provincial prisons in Montreal, Quebec, Canada. Front Public Health
2024;12:1380126. 10.3389/fpubh.2024.1380126
</cite> [<a href="https://doi.org/10.3389/fpubh.2024.1380126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11302355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39109158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Public%20Health&amp;title=Impact%20of%20the%20COVID-19%20pandemic%20on%20hepatitis%20C%20virus%20screening%20in%20provincial%20prisons%20in%20Montreal,%20Quebec,%20Canada&amp;volume=12&amp;publication_year=2024&amp;pages=1380126&amp;pmid=39109158&amp;doi=10.3389/fpubh.2024.1380126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r74">
<span class="label">74.</span><cite>Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, Kelly E, Ko HH, Ma MM, Martin SR, Osiowy C, Ramji A, Tam E, Villeneuve JP. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Can Liver J
2018;1(4):156–217. 10.3138/canlivj.2018-0008
</cite> [<a href="https://doi.org/10.3138/canlivj.2018-0008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9202759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35992619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Liver%20J&amp;title=Management%20of%20Hepatitis%20B%20Virus%20Infection:%202018%20Guidelines%20from%20the%20Canadian%20Association%20for%20the%20Study%20of%20Liver%20Disease%20and%20Association%20of%20Medical%20Microbiology%20and%20Infectious%20Disease%20Canada&amp;volume=1&amp;issue=4&amp;publication_year=2018&amp;pages=156-217&amp;pmid=35992619&amp;doi=10.3138/canlivj.2018-0008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r75">
<span class="label">75.</span><cite>Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Dynamics of viremia in early hepatitis C virus infection. Transfusion
2005;45(6):994–1002. 10.1111/j.1537-2995.2005.04390.x
</cite> [<a href="https://doi.org/10.1111/j.1537-2995.2005.04390.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15934999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transfusion&amp;title=Dynamics%20of%20viremia%20in%20early%20hepatitis%20C%20virus%20infection&amp;volume=45&amp;issue=6&amp;publication_year=2005&amp;pages=994-1002&amp;pmid=15934999&amp;doi=10.1111/j.1537-2995.2005.04390.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Canada Communicable Disease Report are provided here courtesy of <strong>Public Health Agency of Canada</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.14745/ccdr.v51i67a02"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/CCDR-51-223.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (133.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372649/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372649/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372649%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372649/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372649/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372649/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372649/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372649/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372649/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="3QpeUH5ZKdkYPhdxOjv40RCFLzT6MLEPzxqzUuvmW3jnL3OCXLtCCMscZKFISBAA">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
